申请人:Lopez-Tapia Francisco Javier
公开号:US20100160387A1
公开(公告)日:2010-06-24
Compounds of the formula I:
or pharmaceutically acceptable salts thereof, wherein m, n, R
1
, R
2
, R
3
, R
4
and R
5
are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.
式I的化合物:
或其药用可接受的盐,其中m、n、R1、R2、R3、R4和R5如本文所定义。还公开了制备这些化合物的方法,并将这些化合物用于治疗与P2X7嘌呤受体相关的疾病。